- Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy2020 | Publication without faculty affiliation
- Haematotoxicity in imrt/vmat curatively treated anal cancer2020 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2)2017 | Publication without faculty affiliation
- Frontline intensive chemotherapy improves outcome in young, high-risk patients with follicular lymphoma: pair-matched analysis from the Czech Lymphoma Study Group Database2017 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Functional imaging and therapy of neuroendocrine tumors using metaiodobenzylguanidine2011 | Second Faculty of Medicine
- Hematopoietic stem cell transplantation in the treatment of malignant and non-malignant diseases2009 | Second Faculty of Medicine
- Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity.2009 | First Faculty of Medicine
- Study of DNA-ellipticine interaction by capillary electrophoresis with laser-induced fluorescence detection2012 | Faculty of Science, Second Faculty of Medicine
- Study of DNA-ellipticine interaction by capillary electrophoresis with laser-induced fluorescence detection2012 | Second Faculty of Medicine
- Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene2016 | Faculty of Science, Faculty of Medicine in Pilsen
- Enzulutamide in treatment in patients with metastatic castration-resistant prostate cancer after previous chemotherapy2017 | First Faculty of Medicine
- Efficiency and safety of pemetrexed and cisplatin therapy in the adenocarcinoma and large cell cancer types of advanced non-small cell lung cancer (NSCLC)2012 | Publication without faculty affiliation
- Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected "real-world" population2019 | Publication without faculty affiliation
- Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up2010 | Publication without faculty affiliation
- Advantages in Prognosis of Adult Patients with Ewing Sarcoma: 11-years Experiences and Current Treatment Management2018 | Publication without faculty affiliation
- The prognostic effect of neoadjuvant chemoradiotherapy on the change of PD-L1 expression in patients with locally advanced rectal adenocarcinoma2017 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine2006 | Second Faculty of Medicine
- Impact of age on the clinical response of patients with CML treated with imatinib2015 | Faculty of Medicine in Hradec Králové
- Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma2015 | First Faculty of Medicine
- Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer2017 | Publication without faculty affiliation
- Postoperative radiochemotherapy with weekly cisplatin in patients with head and neck cancer Single-institution outcome analysis2012 | First Faculty of Medicine, Third Faculty of Medicine
- Definitive radiochemotherapy with weekly cisplatin in patients with head and neck cancer; single institution outcome analysis2012 | Third Faculty of Medicine
- Plasmafiltration as a possible contributor to kinetic targeting of pegylated liposomal doxorubicin (PLD) in order to prevent organ toxicity and immunosuppression2016 | Faculty of Medicine in Hradec Králové
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)2005 | Third Faculty of Medicine
- Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell LymphomaPublication without faculty affiliation